Opening statements made in Ohio doctor's defamation trial against Mount Carmel
COLUMBUS, Ohio (WCMH) — After two days of jury selection, opening statements were made in the trial between William Husel, a former physician acquitted of 14 murder charges in 2022, and the Mount Carmel Health System.
Wednesday morning started with alternate jurors being selected before Husel's attorney, Jose Baez, began opening statements just before 1:30 p.m. Baez is a Florida-based attorney who also represented Husel during his 2022 murder trial.
'This man has had to endure the unbearable,' Baez said. More than three years after being found not guilty of murder, Husel sued the Mount Carmel Health System, former Mount Carmel CEO and president Edward Lamb, and Mount Carmel's parent company Trinity Health Corporation for defamation.
Baez championed Husel's background as an award-winning doctor before diving into his claim of how Trinity Health used public relations tactics to sway a media campaign against him. Among a large amount of examples shown to the jury, Baez showed an email that gave employees 'kudos' for influencing local newspaper coverage against Husel.
From 2015 to 2018, critically ill patients under Husel's care died from a potentially excessive amount of painkillers. In 2019, Husel faced 14 murder charges in relation to his patients' deaths. A jury ultimately found him not guilty in 2022 after a months-long trial. Husel surrendered his medical license in the aftermath of his trial.
Funeral services held for Morrow County deputy fatally shot on Memorial Day
Husel filed multiple new civil lawsuits which included a 2023 suit for $20 million against Mount Carmel in which Husel's attorneys claim 'malicious prosecution' against him.
This lawsuit was dismissed in March of 2024 before he filed a new suit a month later, which cited public statements from the defendants calling him responsible for patient deaths and attempts to influence local media.
Defense attorney Powell Miller from Michigan firm Miller Law claimed Mount Carmel did not want to go public with the allegations against Husel and said that Husel needs to prove more than just negative statements against him in order to rule it defamation. He also pointed to Lamb's video responses that did not directly name Husel.
He said any statements made did not accuse Husel of any intent to harm patients.
'Dr. Husel cannot hold us responsible for any of his potential damages,' Miller said. 'We never called him a criminal or a killer.'
Witness testimony is expected to begin Thursday morning.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
M-novator Demo Day Ignites Medical Innovation, Shaping the Future of MedTech
TAIPEI, June 6, 2025 /PRNewswire/ -- On the opening day of Medical Taiwan 2025, Mosaic Venture Lab, as a partner of the M-novator, is dedicated to acting as a bridge connecting Taiwan's and international innovative energy. Through its investment and ecosystem collaboration platform, it accelerates the growth of global high-quality startups in Taiwan, fosters cross-border collaborations, and brings more international funding and business opportunities to Taiwan's smart healthcare industry. The M-novator startup teams hail from Taiwan, the United States, South Korea, Belgium, and Israel. Examples include US-based InFocus Therapeutics, which focuses on developing RNA-targeted drugs, and Taiwan's own Pulxion, which has made breakthroughs in AI carotid artery detection, showcasing the international vitality of medical innovation. These pioneering startups, whose technologies represent cutting-edge advancements in the medical field, showcased in their Demo Day pitches precision artificial intelligence for diagnostics and data analysis, intuitive digital health platforms, seamless integration of medical devices (such as advanced endoscopes and smart wearables), and data-driven clinical decision support tools. A key theme of Medical Taiwan 2025 is the significant contribution of ecosystem builders in nurturing early-stage startups to achieve global impact. Johnny Yu, Founder and Chairman of CellTech Innovation Venture Studio and Managing Director of Mosaic Venture Lab, delivered a keynote speech on global MedTech trends and pressures, covering population aging, complex regulatory frameworks, and lengthy development cycles. Johnny highlighted key obstacles faced by early-stage startups: the lab-to-market translation gap, complex regulatory hurdles, funding constraints, and the complexities of market entry. He emphasized that ecosystem builders such as accelerators, venture studios, academic incubators, and government innovation departments play a crucial role in overcoming these challenges. Ryan Jin, Manager at Singapore's Centre for Healthcare Innovation, emphasized in his speech that while innovation is crucial, its effective integration into existing healthcare systems requires strategic partnerships. He acknowledged the common difficulties in collaboration between startups and healthcare institutions, citing systemic misalignments, "last-mile" barriers, and a lack of bridging infrastructure. To overcome these issues, Ryan stressed the need for streamlined processes, strong support for innovation adoption, and the establishment of clear communication channels. A highlight of the Demo Day, the panel discussion "Navigating Taiwan's MedTech Ecosystem" featured panelists including Jowy Tani, CEO of Taipei Medical University BioMed Accelerator; Nina Feng, Managing Director of Vivo Capital Taiwan; and Yenchen Huang, Vice President of Diamond Biofund. The panel aims to provide actionable insights for international MedTech and AI startups seeking to enter and thrive in the Taiwanese and Asian markets, focusing on strategies for clinical adoption, supply chain collaboration, and market entry. Mosaic Venture Lab is a venture capital accelerator focused on digital health, smart mobility, and semiconductor innovation. It collaborates with global automotive OEMs and Tier-1 suppliers to drive technological innovation and optimize business models, and is dedicated to discovering and nurturing innovative technologies from Taiwan, Japan, and South Korea to connect with major European and American companies. Media Contact:Jade ChengSr. Project ManagerMosaic Venture Lab - Partner of Medical Taiwan 2025 M-novatorEmail: jc@ Website: View original content to download multimedia: SOURCE Mosaic Venture Lab Co.,Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Journals
8 hours ago
- Business Journals
AI revolution: Navigating the promises and perils of a new era
At electronic health records innovator ModMed, its proprietary artificial intelligence application, ModMed Scribe, has been trained on millions of patient encounters. It is improving how doctors interact with, diagnose, and care for patients to improve office workflow. JM Family Enterprises use AI-powered tools to help create and test new applications. This is improving the quality of software development and reducing the time required to produce requirements and test cases by approximately 30%. A contact center platform with AI capabilities at BankUnited is exploring how sentiment analysis can help bankers and customers find the solutions that best fit a given situation. Miami Dade College, in collaboration with Microsoft, is applying the technology company's 365 Copilot AI-powered productivity tool atop its suite of applications to drive staff and faculty efficiency. Since implementation, nearly one year ago, adoption is over 90%, which is impressive, understanding that it's a brand-new tool, according to Antonio Delgado, the school's VP of Innovation and Technology Partnerships. This is simply some novel large language (LLM) model application; it's facilitating efficiencies across the school's technology suite. 'The results that we see even before getting to a full year of implementation is an enormous number of hours saved by leveraging the tool,' Delgado said. 'We see greater satisfaction. We see the productivity. And at the end, the outcomes with our students are better communication and better sense of belonging.' AI's promises and potential perils were explored during the recent AI Revolution Roundtable. Held at the Miami offices of the South Florida Business Journal and moderated by Andrew Duffell, president of the Research Park at Florida Atlantic University, leaders from some of the region's leading private and public sector employers discussed the challenges they're facing with artificial intelligence. Deploying AI in the workplace From the debut less than two years ago of generative AI applications like ChatGPT, companies today are turning to agentic AI. These systems can autonomously make decisions and act to achieve goals, often with minimal human intervention. Already, AI in all its forms is delivering a 'noticeable shift from prioritizing large, transformative use cases to simply understanding how to best integrate AI into routine tasks,' said John Damalas, group VP and CTO with JM Family Enterprises, the Deerfield Beach-based automotive distributor and services company. AI is creating an evolving narrative that positions it as a support tool for human-led activities, rather than a total replacement for cognitive work. JM Family's AI Center of Excellence has developed governance frameworks via its AI Council, a cross-functional team that promotes AI initiatives and ensures strategic alignment. It prioritizes responsible AI use with a 'formal process to review use cases for transparency and compliance with regulations, including monitoring proposed regulations in relevant jurisdictions,' Damalas said. Julio Jogaib, CIO with BankUnited, shared that employees must be trained on AI's best uses to advance their organization. This includes creating governance protocols to create standards and guardrails for proper AI usage by the workforce and organization. BankUnited's vendors are using AI in the applications they provide. Jogaib works to ensure the bank and its vendors 'have governance in place surrounding usage, data privacy, and other areas,' he said. It's especially important when client data is being used by vendors to train their systems. 'There is a lot of legal apparatus that needs to be in place and monitoring on what's being done by these platforms,' Jogaib said. 'They may say that they are not using our data. But you have to verify that.' As a health care technology company, ModMed works to ensure the company and its partners have the rights to use data or documents in the development of its platform, from widgets, chatbots, agents or generative AI. Daniel Cane, the company's co-founder and co-CEO, represented ModMed on the roundtable. 'They might have an asterisk by it now and say, 'if you use this new AI agent, we're collecting information to understand how our agent works and better train it in the future,'' Cane said. 'Be careful when you're using third party tools to understand how they're going to use your data.' Jogaib put it more fundamentally: 'You need to have people inside the company capable of thinking.' Training next-gen users Two cohorts of 'students' are emerging in the AI realm. One will be those traditional students in classrooms who are learning coursework to prepare them for future careers. Second are employees who are learning skills - including the use of AI - to serve their companies or future career opportunities. Technology has changed education delivery. Think back to the pandemic, when classrooms from grade school to higher education embraced portable devices and remote learning. AI is continuing that evolution. It's 'personalizing the education journey,' Delgado said. It can identify in-demand jobs, and the skills, degrees, or certificates needed to pursue them. The emergence of LLM applications, like ChatGPT, has students asking a question of the application, then copy/pasting the answer into their schoolwork. How do educators, or even employers, ensure students or workers actually learn and know the material? 'That's a big challenge that I see… the student is not doing the thinking anymore,' Delgado said. 'It's having the skills to embed AI in what you do and still add value, to defend the answer, to think about the abstract. We need to work on changing the way that academia is not only teaching but also assessing learning. Because if not, there is no learning happening.' JM Family invests in workforce development and views AI as an enhancement, not a replacement, for human capability. A critical part of its AI Center of Excellence is giving associates the tools and training needed to learn about AI and understand how to leverage it within their work. The roundtable's moderator, Andrew Duffell of Research Park at FAU, wondered how ModMed is encouraging employees to integrate their own knowledge with AI. Cane explained that the expectation is that employees are problem solvers and eager learners, and they arrive with a fundamental understanding of AI and its potential uses in the organization. Employees' natural curiosity must have them exploring how AI can be a tool to improve effectiveness, he emphasized. 'We are an employer that's using AI throughout our company, whether it's finance, accounting, marketing, software development,' Cane said. 'But we're also creating our AI to solve problems out in the wild.' AI's misperceptions, challenges and threats 'The belief that AI will automatically enhance processes and products can be inaccurate,' Damalas said. 'Similar to the digitization trend of the late 1990s and early 2000s, integrating AI into a business process with considerable inefficiencies may only heighten those inefficiencies, unless the process or product is carefully assessed concerning the specific outcomes or goals that AI is supposed to achieve within its context.' AI can create workplace challenges. According to Damalas, one involves managing change and promoting psychological safety for users as they adopt these technologies. He believes it is essential to address concerns that AI and other emerging technologies may replace jobs and instead encourage users to perceive them as enhancements to their skills and capabilities. Another will be how industries, such as health care, banking and financial services or education, for example, work with policy makers to enhance future regulations around AI. ModMed works with industry governing bodies to advocate for responsible AI applications and implementation. Internally, the company ensures its use of data complies with patient privacy laws, as well as emerging AI responsible-use and transparency guidelines. A company like ModMed's unique place as a developer and user of AI also gives it a role to play as advisor to governing bodies. 'Now is the time to be working with policy makers,' Cane said. 'It's essential that we bring policymakers and governing bodies up to speed on how this content and how this technology can be used in a way that can help people, and try to prevent people from getting hurt by it.' Where some may see regulators or governing bodies as 'the enemy,' Jogaib said the pace of industry innovation places developers and users in an important role as advisor. 'We call regulators our partners,' Jogaib said. 'We show them what they are doing, how we are doing it. We allow them to ask questions and through those questions they not only understand better how we are doing things, but they also take feedback. There must be this interaction, this exchange of experience.' As with any technology, strong internal policies can help thwart misuse and external threats. Companies must bolster and update their cybersecurity apparatus, Jogaib affirmed. Besides, as regulated industries, health care and banking, even education, face the prospect of government involvement - even suspension or revocation of licensure - should they not protect data or otherwise not meet regulations. Dispelling misperceptions Even as AI goes from headlines to frontline use in the workplace, developers and employers are still working to dispel fears and misperceptions that AI will replace workers. In physician practices, Cane said that AI won't replace doctors. Rather, its ModMed Scribe platform is helping doctors focus on practicing medicine, as opposed to rote tasks and administration 'and all of the back office overhead on billing and collecting and working on payers and all the things that happen in the middle where a doctor wants more than anything just to focus on the human being in front of them, the patient,' Cane said. 'It's not uncommon for doctors to spend two or three hours after work in what we call, 'pajama time,' catching up on their notes,' he said. His AI platform takes notes during the visit, writes prescriptions, orders and reviews labs, and handles other documentation - even following up with the patient to ensure compliance. From a more fundamental approach, Delgado noted that organizations need to educate their users - employees, customers, even students, in the case of educators - to ensure they're learning and using best practices. 'We need to really educate our constituents from that perspective about how to leverage it in a positive way, while still making sure they are open to including it as part of the journey,' he said. To Delgado, as business and society embrace agentic AI, or any AI applications for that matter, it still requires human intervention to supervise and hold AI accountable for its outcomes. 'Hallucinations' or incorrect responses remain a serious concern whose prevention requires human oversight. While future autonomous AI presents some dangers, the evolution brings tremendous promise. The embrace of AI 'is not an isolated event. It's a team sport,' Delgado said. 'Everybody, every function, no matter what type of company it is, has a place in the AI game, even if they don't know that yet.'
Yahoo
8 hours ago
- Yahoo
M-novator Demo Day Ignites Medical Innovation, Shaping the Future of MedTech
TAIPEI, June 6, 2025 /PRNewswire/ -- On the opening day of Medical Taiwan 2025, Mosaic Venture Lab, as a partner of the M-novator, is dedicated to acting as a bridge connecting Taiwan's and international innovative energy. Through its investment and ecosystem collaboration platform, it accelerates the growth of global high-quality startups in Taiwan, fosters cross-border collaborations, and brings more international funding and business opportunities to Taiwan's smart healthcare industry. The M-novator startup teams hail from Taiwan, the United States, South Korea, Belgium, and Israel. Examples include US-based InFocus Therapeutics, which focuses on developing RNA-targeted drugs, and Taiwan's own Pulxion, which has made breakthroughs in AI carotid artery detection, showcasing the international vitality of medical innovation. These pioneering startups, whose technologies represent cutting-edge advancements in the medical field, showcased in their Demo Day pitches precision artificial intelligence for diagnostics and data analysis, intuitive digital health platforms, seamless integration of medical devices (such as advanced endoscopes and smart wearables), and data-driven clinical decision support tools. A key theme of Medical Taiwan 2025 is the significant contribution of ecosystem builders in nurturing early-stage startups to achieve global impact. Johnny Yu, Founder and Chairman of CellTech Innovation Venture Studio and Managing Director of Mosaic Venture Lab, delivered a keynote speech on global MedTech trends and pressures, covering population aging, complex regulatory frameworks, and lengthy development cycles. Johnny highlighted key obstacles faced by early-stage startups: the lab-to-market translation gap, complex regulatory hurdles, funding constraints, and the complexities of market entry. He emphasized that ecosystem builders such as accelerators, venture studios, academic incubators, and government innovation departments play a crucial role in overcoming these challenges. Ryan Jin, Manager at Singapore's Centre for Healthcare Innovation, emphasized in his speech that while innovation is crucial, its effective integration into existing healthcare systems requires strategic partnerships. He acknowledged the common difficulties in collaboration between startups and healthcare institutions, citing systemic misalignments, "last-mile" barriers, and a lack of bridging infrastructure. To overcome these issues, Ryan stressed the need for streamlined processes, strong support for innovation adoption, and the establishment of clear communication channels. A highlight of the Demo Day, the panel discussion "Navigating Taiwan's MedTech Ecosystem" featured panelists including Jowy Tani, CEO of Taipei Medical University BioMed Accelerator; Nina Feng, Managing Director of Vivo Capital Taiwan; and Yenchen Huang, Vice President of Diamond Biofund. The panel aims to provide actionable insights for international MedTech and AI startups seeking to enter and thrive in the Taiwanese and Asian markets, focusing on strategies for clinical adoption, supply chain collaboration, and market entry. Mosaic Venture Lab is a venture capital accelerator focused on digital health, smart mobility, and semiconductor innovation. It collaborates with global automotive OEMs and Tier-1 suppliers to drive technological innovation and optimize business models, and is dedicated to discovering and nurturing innovative technologies from Taiwan, Japan, and South Korea to connect with major European and American companies. Media Contact:Jade ChengSr. Project ManagerMosaic Venture Lab - Partner of Medical Taiwan 2025 M-novatorEmail: jc@ Website: View original content to download multimedia: SOURCE Mosaic Venture Lab Co.,Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
